BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noel M, Fiscella K. Disparities in Pancreatic Cancer Treatment and Outcomes. Health Equity. 2019;3:532-540. [PMID: 31663065 DOI: 10.1089/heq.2019.0057] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sugumar K, Hue JJ, Hardacre JM, Ammori JB, Rothermel LD, Dorth J, Saltzman J, Mohamed A, Selfridge JE, Bajor D, Winter JM, Ocuin LM. Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinoma. HPB (Oxford) 2021:S1365-182X(21)01582-3. [PMID: 34465529 DOI: 10.1016/j.hpb.2021.08.938] [Reference Citation Analysis]
2 Bakkila BF, Kerekes D, Nunez-Smith M, Billingsley KG, Ahuja N, Wang K, Oladele C, Johnson CH, Khan SA. Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery. JAMA Netw Open 2022;5:e225664. [PMID: 35377425 DOI: 10.1001/jamanetworkopen.2022.5664] [Reference Citation Analysis]
3 Mickel TA, Kutlu OC, Silberfein EJ, Hsu C, Chai CY, Fisher WE, Van Buren G, Camp ER. Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.02.058] [Reference Citation Analysis]
4 Ladekarl M, Rasmussen LS, Kirkegård J, Chen I, Pfeiffer P, Weber B, Skuladottir H, Østerlind K, Larsen JS, Mortensen FV, Engberg H, Møller H, Fristrup CW. Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer. Acta Oncol 2022;61:277-85. [PMID: 34879787 DOI: 10.1080/0284186X.2021.2012252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Permuth JB, Dezsi KB, Vyas S, Ali KN, Basinski TL, Utuama OA, Denbo JW, Klapman J, Dam A, Carballido E, Kim DW, Pimiento JM, Powers BD, Otto AK, Choi JW, Chen DT, Teer JK, Beato F, Ward A, Cortizas EM, Whisner SY, Williams IE, Riner AN, Tardif K, Velanovich V, Karachristos A, Douglas WG, Legaspi A, Allan BJ, Meredith K, Molina-Vega MA, Bao P, St Julien J, Huguet KL, Green L, Odedina FT, Kumar NB, Simmons VN, George TJ, Vadaparampil ST, Hodul PJ, Arnoletti JP, Awad ZT, Bose D, Jiang K, Centeno BA, Gwede CK, Malafa M, Judge SM, Judge AR, Jeong D, Bloomston M, Merchant NB, Fleming JB, Trevino JG, On Behalf Of The Florida Pancreas Collaborative. The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer. Cancers (Basel) 2021;13:809. [PMID: 33671939 DOI: 10.3390/cancers13040809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kills First CC, Sutton TL, Shannon J, Brody JR, Sheppard BC. Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongs. Cancer 2022. [PMID: 35132620 DOI: 10.1002/cncr.34118] [Reference Citation Analysis]
7 Dahiya DS, Inamdar S, Perisetti A, Kichloo A, Singh A, Solanki S, Solanki D, Al-haddad M. Decreasing length of stay and inpatient mortality associated with pancreatic cancer hospitalizations: A United States national survey from 2008 to 2017. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.04.008] [Reference Citation Analysis]
8 Bingmer KE, Hue JJ, Sugumar K, Ammori JB, Rothermel LD, Winter JM, Hardacre JM, Ocuin LM. Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients. HPB (Oxford) 2021:S1365-182X(21)00589-X. [PMID: 34247942 DOI: 10.1016/j.hpb.2021.06.418] [Reference Citation Analysis]
9 Molina G, Clancy TE, Tsai TC, Lam M, Wang J. Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma. Ann Surg Oncol 2021;28:1088-96. [PMID: 32651695 DOI: 10.1245/s10434-020-08717-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Azap RA, Diaz A, Hyer JM, Tsilimigras DI, Mirdad RS, Ejaz A, Pawlik TM. Impact of Race/Ethnicity and County-Level Vulnerability on Receipt of Surgery Among Older Medicare Beneficiaries With the Diagnosis of Early Pancreatic Cancer. Ann Surg Oncol 2021. [PMID: 33844130 DOI: 10.1245/s10434-021-09911-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Calvillo-Ortiz R, Polanco-Santana JC, Castillo-Angeles M, Allar BG, Anguiano-Landa L, Ghaffarpasand E, Barrows C, Callery MP, Kent TS. Language Proficiency and Survival in Pancreatic Cancer: a Propensity Score-Matched Analysis. J Gastrointest Surg 2021. [PMID: 34258672 DOI: 10.1007/s11605-021-05081-3] [Reference Citation Analysis]
12 Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY. Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients. World J Clin Cases 2021; 9(4): 792-800 [PMID: 33585625 DOI: 10.12998/wjcc.v9.i4.792] [Reference Citation Analysis]
13 Zarate Rodriguez JG, Cos H, Williams GA, Woolsey CA, Fields RC, Strasberg SM, Doyle MB, Khan AS, Chapman WC, Hammill CW, Hawkins WG, Sanford DE. Inability to manage non-severe complications on an outpatient basis increases non-white patient readmission rates after pancreaticoduodenectomy: A large metropolitan tertiary care center experience. Am J Surg 2021:S0002-9610(21)00240-3. [PMID: 33906729 DOI: 10.1016/j.amjsurg.2021.04.011] [Reference Citation Analysis]
14 Eskander MF, Hamad A, Li Y, Fisher JL, Oppong B, Obeng-Gyasi S, Tsung A. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes. Surgery 2021:S0039-6060(21)00992-2. [PMID: 34876291 DOI: 10.1016/j.surg.2021.10.027] [Reference Citation Analysis]
15 Hamad A, DePuccio M, Reames BN, Dave A, Kurien N, Cloyd JM, Shen C, Pawlik TM, Tsung A, McAlearney AS, Ejaz A. Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma. J Gastrointest Surg 2021. [PMID: 33768427 DOI: 10.1007/s11605-021-04984-5] [Reference Citation Analysis]
16 Bonner SN, Wakam GK, Kwayke G, Scott JW. COVID-19 and Racial Disparities: Moving Towards Surgical Equity. Ann Surg 2020;272:e224-5. [PMID: 32541229 DOI: 10.1097/SLA.0000000000004111] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol 2021; 27(27): 4298-4321 [PMID: 34366606 DOI: 10.3748/wjg.v27.i27.4298] [Reference Citation Analysis]
18 Mitsakos AT, Dennis SO, Parikh AA, Snyder RA. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol 2021;123:970-7. [PMID: 33497474 DOI: 10.1002/jso.26383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mishra A, DeLia D, Zeymo A, Aminpour N, McDermott J, Desale S, Al-Refaie WB. ACA Medicaid expansion reduced disparities in use of high-volume hospitals for pancreatic surgery. Surgery 2021:S0039-6060(21)00493-1. [PMID: 34303545 DOI: 10.1016/j.surg.2021.05.033] [Reference Citation Analysis]
20 Islami F, Guerra CE, Minihan A, Yabroff KR, Fedewa SA, Sloan K, Wiedt TL, Thomson B, Siegel RL, Nargis N, Winn RA, Lacasse L, Makaroff L, Daniels EC, Patel AV, Cance WG, Jemal A. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA Cancer J Clin 2021. [PMID: 34878180 DOI: 10.3322/caac.21703] [Reference Citation Analysis]
21 Doria C, De Deyne P, Dolan S, Chung J, Yatcilla K, Zarifian L, Remstein R, Schwartz E. Municipality and Adjusted Gross Income Influence Outcome of Patients Diagnosed with Pancreatic Cancer in a Newly Developed Cancer Center in Mercer County New Jersey, USA, a Single Center Study. Cancers (Basel) 2021;13:1498. [PMID: 33805136 DOI: 10.3390/cancers13071498] [Reference Citation Analysis]
22 Walker EJ, Goldberg D, Gordon KM, Pedley C, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH, Blanco AM, Dhawan M. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma. Oncologist 2021;26:e1982-91. [PMID: 34506673 DOI: 10.1002/onco.13968] [Reference Citation Analysis]
23 Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY. Radioactive 125I seed implantation for locally advanced pancreatic cancer: A retrospective analysis of 50 cases. World J Clin Cases 2020; 8(17): 3743-3750 [PMID: 32953850 DOI: 10.12998/wjcc.v8.i17.3743] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Hamad A, Eskander MF, Shen C, Bhattacharyya O, Fisher JL, Oppong BA, Obeng-Gyasi S, Tsung A. In search of lost time: Delays in adjuvant therapy for pancreatic adenocarcinoma among under-resourced patient populations. Surgery 2022:S0039-6060(22)00248-3. [PMID: 35595567 DOI: 10.1016/j.surg.2022.04.018] [Reference Citation Analysis]
25 Zhu F, Wang H, Ashamalla H. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types. Pancreas. 2020;49:1355-1363. [PMID: 33122525 DOI: 10.1097/mpa.0000000000001688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Del Valle JP, Fillmore NR, Molina G, Fairweather M, Wang J, Clancy TE, Ashley SW, Urman RD, Whang EE, Gold JS. Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration. Ann Surg Oncol. [DOI: 10.1245/s10434-021-11250-0] [Reference Citation Analysis]
27 Calderwood AH, Sawhney MS, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-johnson DL, Sahani DV, Stoffel EM, Vollmer CM, Al-haddad MA, Amateau SK, Buxbaum JL, Dimaio CJ, Fujii-lau LL, Jamil LH, Jue TL, Law JK, Lee JK, Naveed M, Pawa S, Storm AC, Qumseya BJ. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence. Gastrointestinal Endoscopy 2022. [DOI: 10.1016/j.gie.2021.12.002] [Reference Citation Analysis]
28 Kutzler HL, Peters J, O’sullivan DM, Williamson A, Cheema F, Ebcioglu Z, Einstein M, Rochon C, Ye X, Sheiner P, Singh JU, Sotil EU, Swales C, Serrano OK. Disparities in End-Organ Care for Hispanic Patients with Kidney and Liver Disease: Implications for Access to Transplantation. Curr Surg Rep 2020;8. [DOI: 10.1007/s40137-020-00248-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Papageorge MV, Evans DB, Tseng JF. Health Care Disparities and the Future of Pancreatic Cancer Care. Surg Oncol Clin N Am 2021;30:759-71. [PMID: 34511195 DOI: 10.1016/j.soc.2021.06.012] [Reference Citation Analysis]
30 Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. The American Journal of Surgery 2021;222:10-7. [DOI: 10.1016/j.amjsurg.2020.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Francis DB, Pilny A, Zelaya CM. Predicting interpersonal cancer talk among Black women in the United States following Aretha Franklin’s death: The role of network-level factors. Journal of Applied Communication Research. [DOI: 10.1080/00909882.2022.2063029] [Reference Citation Analysis]
32 Hoehn RS, Rieser CJ, Phelos H, Sabik LM, Nassour I, Khan S, Kaltenmeier C, Paniccia A, Zureikat AH, Tohme ST. Medicaid expansion and the management of pancreatic cancer. J Surg Oncol 2021;124:324-33. [PMID: 33939838 DOI: 10.1002/jso.26515] [Reference Citation Analysis]
33 Hao S, Mitsakos A, Irish W, Tuttle-Newhall JE, Parikh AA, Snyder RA. Differences in receipt of multimodality therapy by race, insurance status, and socioeconomic disadvantage in patients with resected pancreatic cancer. J Surg Oncol 2022. [PMID: 35315932 DOI: 10.1002/jso.26859] [Reference Citation Analysis]
34 Wang C, Huang B, Sun L, Wang X, Zhou B, Tang H, Geng W. MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells. Biomed Pharmacother 2021;144:112325. [PMID: 34656065 DOI: 10.1016/j.biopha.2021.112325] [Reference Citation Analysis]